Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme [Phase 1]
Phase 1 clinical trial evaluating immunogene-modified T (IgT) cells for glioblastoma multiforme; currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
A clinical trial update focusing on collection of blood and urine samples from patients receiving radiation therapy for glioblastoma multifo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors [Phase 1]
Phase 1 trial updating the investigation of HSV-1 G207 for children with recurrent or refractory cerebellar brain tumors; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme [Phase 1]
A Phase 1 clinical trial evaluating B7-H3 CAR T cells (B7-H3CART) for recurrent glioblastoma multiforme is currently recruiting, sponsored b…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: WBSI Guided Personalized Delivery of TTFields [NA]
This clinical trials entry reports that a Penn Medicine Abramson Cancer Center study evaluating WBSI-guided, personalized delivery of tumor-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients [Phase 2]
Phase 2 clinical trial comparing chemoradiotherapy versus chemotherapy for elderly and frail patients with glioblastoma multiforme; recruitm…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
This entry provides an update on an ongoing clinical trial aimed at improving understanding of glioblastoma by preserving biologically activ…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) [Phase 1]
Phase 1 study evaluating re-administration of C134 in patients with recurrent glioblastoma and related brain gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme [Phase 2]
Phase 2 trial update for glioblastoma multiforme evaluating Subventricular Zone-targeted therapy in combination with temozolomide; the study…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial [EARLY_Phase 1]
This document reports the termination of a Phase 0/early Phase 1 trial evaluating repurposed posaconazole for glioblastoma, with results pos…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating high-dose ascorbate (vitamin C) for glioblastoma multiforme is currently active but not recruiting.
-
FDA approval · 2025-10-27FDA Approved: LOMUSTINE — Original Application (Carnegie Pharmaceuticals LLC)
FDA approves Carnegie Pharmaceuticals LLC's original application for lomustine (LOMUSTINE), making a generic version of the chemotherapy dru…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM [Phase 2]
A Phase 2 study evaluating NanO2 combined with radiation and temozolomide in newly diagnosed glioblastoma multiforme is ongoing. The study s…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab [Phase 1, Phase 2]
Clinical trial update for recurrent high-grade glioma treated with APG-157 in combination with bevacizumab, currently recruiting in Phase 1/…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: 11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET) [Phase 2]
Phase 2 clinical trial evaluating 11C-methionine for diagnostics and management of glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: G-CSF After Chemo-radiation in Patients With Glioblastoma [Phase 2]
This document reports a Phase 2 clinical trial evaluating the use of granulocyte colony-stimulating factor (G-CSF) after chemotherapy and ra…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]
A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 clinical trial evaluating dichloroacetate (DCA) for glioblastoma multiforme; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating QH104 cell injections for malignant brain gliomas, including glioblastoma multiforme and other high-gr…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial [NA]
Pilot trial assessing low-intensity oscillatory magnetic therapy for newly diagnosed glioblastoma multiforme is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
A clinical trial investigating PSMA expression in glioblastoma after VEGF blockade with bevacizumab is currently NOT_YET_RECRUITING. The stu…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Tamoxifen Versus Etoposide After First Recurrence in GBM Patients [Phase 2]
A Phase 2 clinical trial comparing tamoxifen versus etoposide after first recurrence in glioblastoma multiforme patients is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
A clinical trial from Washington University School of Medicine is exploring resting-state MRI combined with machine learning to guide neuron…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection [EARLY_Phase 1]
A Phase 0/I study evaluating ribociclib in combination with everolimus in preoperative recurrent high-grade glioma patients scheduled for re…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Trial of Ipatasertib in Combination With Atezolizumab [Phase 1, Phase 2]
Update on a Phase 1/2 trial of ipatasertib in combination with atezolizumab for solid tumors, including glioblastoma multiforme and metastat…